Ives Jeffrey L. has filed 14 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 12800 shares of Acumen Pharmaceuticals, Inc. ($ABOS) on June 04, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | A | Common Stock | 12800 | $0.00 | 12,800.0000 | 60,573,425 | 9999.99% | 0.02% |
| June 4, 2025 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 60,573,425 | 9999.99% | 0.03% |
| June 10, 2024 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Ives Jeffrey L. | Not found | A | Common Stock | 150647 | $0.00 | 198,485.0000 | 1,516,336 | 314.91% | 9.93% |
| June 4, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Ives Jeffrey L. | Not found | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 1,516,336 | 9999.99% | 12.86% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | M | Common Stock | 39149 | $0.72 | 39,149.0000 | 0 | 9999.99% | 0.00% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | S | Common Stock | 39149 | $6.48 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | M | Common Stock | 2800 | $1.19 | 2,800.0000 | 0 | 9999.99% | 0.00% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | S | Common Stock | 2800 | $6.66 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | M | Stock Option (right to buy) | 39149 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | M | Stock Option (right to buy) | 2800 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 6, 2023 | Acumen Pharmaceuticals, Inc. | $ABOS | Ives Jeffrey L. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Ives Jeffrey L. | Director | A | Common Stock | 32362 | $0.00 | 47,838.0000 | 53,872,038 | 209.11% | 0.06% |
| June 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Ives Jeffrey L. | Director | A | Stock Option (Right to Buy) | 44961 | $0.00 | 44,961.0000 | 53,872,038 | 9999.99% | 0.08% |